» Articles » PMID: 34784912

The Protective Effects of Pericyte-derived Microvesicles on Vascular Endothelial Functions Via CTGF Delivery in Sepsis

Overview
Publisher Biomed Central
Date 2021 Nov 17
PMID 34784912
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is well known that sepsis is a prevalent severe disease caused by infection and the treatment strategies are limited. Recently pericyte-derived microvesicles (PMVs) were confirmed to be therapeutic in many diseases, whether PMVs can protect vascular endothelial cell (VEC) injury is unknown.

Methods: Pericytes were extracted from the retina of newly weaned rats, and PMVs were collected after starvation and characterized by flow-cytometry and transmission electron microscopy. First, the effect of PMVs on pulmonary vascular function in septic rats was measured via intravenous administration with HE staining, immunofluorescence, and Elisa analysis. Then, PMVs were co-incubated with VECs in the presence of lipopolysaccharide (LPS), and observed the protective effect of PMVs on VECs. Next, the proteomic analysis and further Gene Ontology (GO) enrichment analysis were performed to analyze the therapeutic mechanism of PMVs, and the angiogenesis-related protein CTGF was highly expressed in PMVs. Finally, by CTGF upregulation and downregulation in PMV, the role of PMV-carried CTGF was investigated.

Results: PMVs restored the proliferation and angiogenesis ability of pulmonary VECs, and alleviated pulmonary vascular leakage in septic rats and LPS-stimulated VECs. Further study showed that PMVs delivered CTGF to VECs, and subsequently activated ERK1/2, and increased the phosphorylation of STAT3, thereby improving the function of VECs. The further study found CD44 mediated the absorption and internalization of PMVs to VECs, the anti-CD44 antibody inhibited the protective effect of PMVs.

Conclusions: PMVs may delivery CTGF to VECs, and promote the proliferation and angiogenesis ability by activating the CTGF-ERK1/2-STAT3 axis, thereby protecting pulmonary vascular function in sepsis. The therapeutic effect of PMVs was highly related to CD44-mediated absorption. Video Abstract.

Citing Articles

Pericyte-derived extracellular vesicles improve vascular barrier function in sepsis via the Angpt1/PI3K/AKT pathway and pericyte recruitment: an in vivo and in vitro study.

Zhang Z, Yang A, Luo X, Zhou H, Liu Y, Bao D Stem Cell Res Ther. 2025; 16(1):70.

PMID: 39940043 PMC: 11823130. DOI: 10.1186/s13287-025-04201-z.


Corylin alleviated sepsis-associated cardiac dysfunction via attenuating inflammation through downregulation of microRNA-214-5p.

Li C, Hou D, Huang Y, Liu Y, Li Y, Wang C Toxicol Res (Camb). 2024; 13(3):tfae081.

PMID: 38855635 PMC: 11161260. DOI: 10.1093/toxres/tfae081.


Effect of antibody-mediated connective tissue growth factor neutralization on lung edema in ventilator-induced lung injury in rats.

van den Brom C, Bozic C, Polet C, Bongers A, Tuip-de Boer A, Ibelings R Mol Med. 2024; 30(1):68.

PMID: 38778274 PMC: 11112940. DOI: 10.1186/s10020-024-00829-4.


Polarity reversal of canine intestinal organoids reduces proliferation and increases cell death.

Csukovich G, Wagner M, Walter I, Burger S, Tschulenk W, Steinborn R Cell Prolif. 2023; 57(2):e13544.

PMID: 37697686 PMC: 10849783. DOI: 10.1111/cpr.13544.


Research advances in cochlear pericytes and hearing loss.

Shi X Hear Res. 2023; 438:108877.

PMID: 37651921 PMC: 10538405. DOI: 10.1016/j.heares.2023.108877.


References
1.
Kruger-Genge A, Blocki A, Franke R, Jung F . Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18). PMC: 6769656. DOI: 10.3390/ijms20184411. View

2.
Wang L, Tsai H, Cheng Y, Lin C, Huang Y, Tsai C . CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling. Cancer Lett. 2017; 391:28-37. DOI: 10.1016/j.canlet.2017.01.013. View

3.
Gonzalez D, Brandan E . CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases. Mol Neurobiol. 2019; 56(8):5911-5916. DOI: 10.1007/s12035-019-1490-9. View

4.
Saint-Pol J, Gosselet F, Duban-Deweer S, Pottiez G, Karamanos Y . Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Cells. 2020; 9(4). PMC: 7226770. DOI: 10.3390/cells9040851. View

5.
Mathieu M, Nevo N, Jouve M, Valenzuela J, Maurin M, Verweij F . Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun. 2021; 12(1):4389. PMC: 8289845. DOI: 10.1038/s41467-021-24384-2. View